Nephros (NEPH) EBT Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Nephros (NEPH) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -719.00 |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 236.00 |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 295.00 |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 687.00 |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 88.00 |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 374.00 |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -938.00 |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 343.00 |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 165.00 |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 1,454.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,454.00 |
| Mar 31, 2026 | -915.00 |
| Dec 31, 2025 | -809.00 |
| Sep 30, 2025 | 194.00 |
| Jun 30, 2025 | 1,445.00 |
| Mar 31, 2025 | 1,698.00 |
| Dec 31, 2024 | 3,504.00 |
| Sep 30, 2024 | 1,033.00 |
| Jun 30, 2024 | 302.00 |
| Mar 31, 2024 | 207.00 |
| Dec 31, 2023 | 131.00 |
| Sep 30, 2023 | 4,804.00 |
| Jun 30, 2023 | 1,683.00 |
| Mar 31, 2023 | 6,400.00 |
| Dec 31, 2022 | -18.00 |
| Sep 30, 2022 | -2,176.00 |
| Jun 30, 2022 | 2,091.00 |
| Mar 31, 2022 | -3,440.00 |
| Dec 31, 2021 | 456.00 |
| Sep 30, 2021 | 1,342.00 |